PAMELOR Side Effects

6917733-5 | Irritability, Sluggishness
on Sep 21, 2009 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), sleep disorder (What is sleep disorder?) and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: irritability, sluggishness. Pamelor dosage: 25 Mg, Tid. During the same period patient was treated with NORPRESS (25 Mg, 2 Tabs Bid) (View Norpress Review and Norpress Label ), CLONAZEPAM (0.5 Mg, Prn) (View Clonazepam Review and Clonazepam Label ), SEROQUEL (Unk) (View Seroquel Review and Seroquel Label ), LITHIUM (250 Mg, Tid) (View Lithium Review and Lithium Label ).

6917732-3 | Arrhythmia, Heart Rate Increased, Malaise, Nightmare, Panic Attack
Patient was taking Pamelor (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), heart rate increased, malaise, nightmare, panic attack on Oct 08, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with depression (What is depression?), panic disorder (What is panic disorder?), sleep disorder (What is sleep disorder?), hypothyroidism, uterine pain, uterine haemorrhage and. Pamelor dosage: 3 Caps At Night. During the same period patient was treated with NORTRIPTYLINE HYDROCHLORIDE (View Nortriptyline Hydrochloride Review and Nortriptyline Hydrochloride Label ), KLONOPIN (0.5 Mg, Unk) (View Klonopin Review and Klonopin Label ), METHYLPHENIDATE (5 Mg,1 Tab Am, 1/2 Tab Pm) (View Methylphenidate Review and Methylphenidate Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOVIA 1/35E 21 (Unk) (View Zovia 1/35e-21 Review and Zovia 1/35e-21 Label ), ZOVIA 1/35E 21 (View Zovia 1/35e-21 Review and Zovia 1/35e-21 Label ).

6855766-8 | Suicide Attempt
Adverse event was reported on Jul 06, 2010 by a Female patient taking Pamelor (View Usage) (Dosage: Unk) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 66 years of age, After Pamelor was administered, patient had the following side effects: suicide attempt. During the same period patient was treated with AVENTYL HYDROCHLORIDE (Unk) (View Aventyl Hydrochloride Review and Aventyl Hydrochloride Label ), AVONEX /05982701/ (30 ?g, Weekly) (View Avonex /05982701/ Review and Avonex /05982701/ Label ). Patient was hospitalized.

6704638-8 | Completed Suicide
on Apr 20, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Pamelor dosage: Unk.


6598727-9 | Cardiac Arrest, Cardio-respiratory Arrest, Completed Suicide
on Jan 05, 2010 Female patient from UNITED STATES , 44 years of age, was treated with Pamelor (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, completed suicide. Pamelor dosage: . Patient was hospitalized.

6598719-X |
Patient was taking Pamelor (View Usage). on Jan 05, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, . Pamelor dosage: . During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

6598703-6 | Completed Suicide
Adverse event was reported on Jan 05, 2010 by a Male patient taking Pamelor (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CARDIAC GLYCOSIDES (View Cardiac Glycosides Review and Cardiac Glycosides Label ), BARBITURATES (View Barbiturates Review and Barbiturates Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), BUSPIRONE HCL (View Buspirone Hcl Review and Buspirone Hcl Label ).

6598698-5 | Completed Suicide
on Jan 05, 2010 Female patient from UNITED STATES , 49 years of age, was treated with Pamelor (View Usage). Patient had the following side effects: completed suicide. Pamelor dosage: .

6598697-3 | Cardiac Arrest, Cardio-respiratory Arrest, Completed Suicide
on Jan 05, 2010 Female patient from UNITED STATES , 52 years of age, was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, completed suicide. Pamelor dosage: . During the same period patient was treated with CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ).

6597643-6 | Completed Suicide
Patient was taking Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jan 05, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, . Pamelor dosage: . During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), SALICYLATES NOS (View Salicylates Nos Review and Salicylates Nos Label ), BENZODIAZEPINE (View Benzodiazepine Review and Benzodiazepine Label ).

6597642-4 | Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Jan 05, 2010 by a Male patient taking Pamelor (View Usage) (Dosage: ) . Location: UNITED STATES , 43 years of age, Patient had the following side effects: cardio-respiratory arrest, completed suicide.

6597641-2 | Completed Suicide
on Jan 05, 2010 Female patient from UNITED STATES , 35 years of age, was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: completed suicide. Pamelor dosage: . During the same period patient was treated with OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ).

6551426-1 | Completed Suicide
on Jan 15, 2010 Female patient from UNITED KINGDOM , 55 years of age, was diagnosed with major depression and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Pamelor dosage: Unk.

6551032-9 | Bundle Branch Block Left, Ventricular Fibrillation
Patient was taking Pamelor (View Usage). Patient had the following side effects: bundle branch block left, ventricular fibrillation on Jan 15, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, . Pamelor dosage: Unk. During the same period patient was treated with CHLORPROMAZINE (Unk) (View Chlorpromazine Review and Chlorpromazine Label ), AMITRIPTYLINE HCL (Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), DIURETICS (Unk) (View Diuretics Review and Diuretics Label ).

6520204-1 | Bipolar Disorder, Depressed Mood
Adverse event was reported on Dec 14, 2009 by a Male patient taking Pamelor (View Usage) (Dosage: 25 Mg, 1 Tablet At Night) was diagnosed with psychomotor hyperactivity and. Location: BRAZIL , 17 years of age, After Pamelor was administered, patient had the following side effects: bipolar disorder (What is bipolar disorder?), depressed mood. During the same period patient was treated with RITALIN (10 Mg, Qd) (View Ritalin Review and Ritalin Label ).

6462668-8 | Brugada Syndrome, Convulsion
on Nov 19, 2009 Male patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: brugada syndrome, convulsion. Pamelor dosage: . During the same period patient was treated with MIANSERIN HYDROCHLORIDE (View Mianserin Hydrochloride Review and Mianserin Hydrochloride Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), AMANTADINE (View Amantadine Review and Amantadine Label ).

6457681-0 | Ageusia, Constipation, Costochondritis, Dry Mouth, Fear, Hypophagia, Mobility Decreased, Orthostatic Hypotension
on Nov 17, 2009 Female patient from UNITED STATES , 71 years of age, was diagnosed with depression (What is depression?) and was treated with Pamelor (View Usage). Patient had the following side effects: ageusia, constipation (What is constipation?), costochondritis, dry mouth, fear, hypophagia, mobility decreased, orthostatic hypotension. Pamelor dosage: 50 Mg, Qd. During the same period patient was treated with QUETIAPINE (300 Mg, Hs) (View Quetiapine Review and Quetiapine Label ), VENLAFAXINE (37.5 Mg, Unk) (View Venlafaxine Review and Venlafaxine Label ), RISPERIDONE (1 Mg, Qhs) (View Risperidone Review and Risperidone Label ).

6342201-1 | Deafness Bilateral, Tinnitus
Patient was taking Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: deafness bilateral, tinnitus (What is tinnitus?) on Sep 04, 2009 from UNITED STATES Additional patient health information: Female patient , 41 years of age, weighting 135.0 lb, was diagnosed with depression (What is depression?) and. Pamelor dosage: 1 Capsule By Mouth Every Night At Bed Po. During the same period patient was treated with NORTRIPTYLINE HCL (1 Capsule By Mouth Every Night At Bed Po) (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), PREMPRO (View Prempro Review and Prempro Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PREVACID (View Prevacid Review and Prevacid Label ), GERD CALCIUM (View Gerd Calcium Review and Gerd Calcium Label ), D VITAMIN (View D Vitamin Review and D Vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ).

6303406-9 | Off Label Use, Therapeutic Response Unexpected
Adverse event was reported on Dec 08, 2008 by a Female patient taking Pamelor (View Usage) (Dosage: Unk) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 85 years of age, Patient experienced the following unwanted or unexpected effects: off label use, therapeutic response unexpected.

6303359-3 | Dysgeusia, Insomnia, Off Label Use, Pollakiuria
on Oct 01, 2008 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with pain (What is pain?), nervous system disorder, depression (What is depression?), pain in extremity, back pain (What is back pain?), abdominal discomfort, blood cholesterol increased and was treated with Pamelor (View Usage). Patient had the following side effects: dysgeusia, insomnia, off label use, pollakiuria. Pamelor dosage: 50 Mg, One Capsule Tid. During the same period patient was treated with LORTAB (2 Tabs, Qd) (View Lortab Review and Lortab Label ), CELEBREX (100 Mg, Bid) (View Celebrex Review and Celebrex Label ), PROTONIX /01263201/ (Unk, Qd) (View Protonix /01263201/ Review and Protonix /01263201/ Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ).

6303356-8 | Anger, Depressed Mood, Fatigue, Muscle Tightness, Pain, Social Avoidant Behaviour, Suicidal Ideation
on Dec 02, 2008 Male patient from UNITED STATES , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: anger, depressed mood, fatigue, muscle tightness, pain (What is pain?), social avoidant behaviour, suicidal ideation. Pamelor dosage: 50 Mg, Qd. During the same period patient was treated with ABILIFY (2 Mg, Qd) (View Abilify Review and Abilify Label ).

6303355-6 | Aggression, Antisocial Behaviour, Irritability, Restlessness
Patient was taking Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, antisocial behaviour, irritability, restlessness on Jan 06, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 250.0 lb, was diagnosed with depression (What is depression?), hypothyroidism and. Pamelor dosage: Unk. During the same period patient was treated with SYNTHROID (100 Ug, Qd) (View Synthroid Review and Synthroid Label ), ABILIFY (View Abilify Review and Abilify Label ).

6303354-4 | Off Label Use, Tachycardia
Adverse event was reported on Apr 22, 2009 by a Female patient taking Pamelor (View Usage) (Dosage: 20 Mg, Daily) was diagnosed with abdominal discomfort and. Location: UNITED STATES , 45 years of age, Patient had the following side effects: off label use, tachycardia.

6296312-X | Cardiotoxicity
on Jul 24, 2009 Female patient from UNITED STATES , 50 years of age, weighting 120.0 lb, was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: cardiotoxicity. Pamelor dosage: 150 Mg, Qd, At Bedtime. During the same period patient was treated with TELITHROMYCIN (400 Mg, Bid For Five Days) (View Telithromycin Review and Telithromycin Label ), VALSARTAN/HYDROCHLOORTHIAZIDE (40/6.25 Mg Daily) (View Valsartan/hydrochloorthiazide Review and Valsartan/hydrochloorthiazide Label ), WARFARIN SODIUM (5 Mg, Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ), ESOMEPRAZOLE MAGNESIUM (40 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ALPRAZOLAM (1 Mg, Qd At Bedtime) (View Alprazolam Review and Alprazolam Label ), LORAZEPAM (1 Mg, At Bedtime As Needed) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6154881-4 | Abdominal Pain Upper, Cold Sweat, Feeling Cold, Feeling Hot, Headache, Hepatomegaly, Hyperhidrosis, Insomnia, Muscle Contractions Involuntary
on Apr 02, 2009 Female patient from BRAZIL , 31 years of age, weighting 160.9 lb, was diagnosed with anxiety disorder and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, cold sweat, feeling cold, feeling hot, headache (What is headache?), hepatomegaly, hyperhidrosis, insomnia, muscle contractions involuntary. Pamelor dosage: 50 Mg, Qd. During the same period patient was treated with TRILEPTAL (300 Mg, Qd) (View Trileptal Review and Trileptal Label ), TEGRETOL (200 Mg, Qd (night)) (View Tegretol Review and Tegretol Label ), FLUOXETINE (20 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), RIVOTRIL (0.5 Mg, Qd) (View Rivotril Review and Rivotril Label ), AMITRIPTLINE HYDROCHLORIDE TAB (20 Mg, Qd) (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ).

6138543-5 | Cardio-respiratory Arrest
Patient was taking Pamelor (View Usage). Patient had the following side effects: cardio-respiratory arrest on Jan 30, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Pamelor dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6138061-4 | Completed Suicide
Adverse event was reported on Jan 30, 2009 by a Female patient taking Pamelor (View Usage) (Dosage: ) . Location: UNITED STATES , 69 years of age, After Pamelor was administered, patient had the following side effects: completed suicide. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6125733-0 | Cardiac Arrest, Cardio-respiratory Arrest, Completed Suicide
on Jan 30, 2009 Female patient from UNITED STATES , 42 years of age, was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, completed suicide. Pamelor dosage: . During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

5964469-3 | Anger, Blood Urine Present, Communication Disorder, Condition Aggravated, Crying, Depression, Insomnia, Mood Swings
on Nov 24, 2008 Male patient from UNITED STATES , 57 years of age, weighting 210.0 lb, was diagnosed with depression (What is depression?), male sexual dysfunction and was treated with Pamelor (View Usage). Patient had the following side effects: anger, blood urine present, communication disorder, condition aggravated, crying, depression (What is depression?), insomnia, mood swings. Pamelor dosage: 10 Mg 7 Capsules @ P.m. Po.

5930694-0 | Blood Pressure Increased
Patient was taking Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: blood pressure increased on May 02, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 149.9 lb, was diagnosed with panic attack and. Pamelor dosage: 25 Mg, Tid, Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5822144-X | Depression, Impaired Work Ability, Memory Impairment, Swelling, Tachycardia, Weight Increased
Adverse event was reported on Jul 16, 2008 by a Female patient taking Pamelor (View Usage) (Dosage: 75 Mg, Bid) was diagnosed with depression (What is depression?), mitral valve prolapse and. Location: BRAZIL , 41 years of age, weighting 173.1 lb, Patient experienced the following unwanted or unexpected effects: depression (What is depression?), impaired work ability, memory impairment, swelling, tachycardia, weight increased. During the same period patient was treated with TOFRANIL (Unk) (View Tofranil Review and Tofranil Label ), TRICYCLIC ANTIDEPRESSANTS (View Tricyclic Antidepressants Review and Tricyclic Antidepressants Label ), PROPRANOLOL (40 Mg, (2 Tabs Morning+1 Tab Lunch+1 Tab Night)) (View Propranolol Review and Propranolol Label ), LITHIUM CARBONATE (600 Mg/day) (View Lithium Carbonate Review and Lithium Carbonate Label ), CLONAZEPAM (2 Mg, Unk) (View Clonazepam Review and Clonazepam Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5520448-1 | Aggression, Dementia Alzheimer's Type
on Nov 08, 2007 Female patient from BRAZIL , 88 years of age, weighting 165.3 lb, was diagnosed with depression (What is depression?), gastric disorder, dementia alzheimer's type, pain (What is pain?), cardiovascular disorder and was treated with Pamelor (View Usage). Patient had the following side effects: aggression, dementia alzheimer's type. Pamelor dosage: 2 Spoon At Night. During the same period patient was treated with NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), ERANZ (10 Mg, Qd) (View Eranz Review and Eranz Label ), PREXIGE (100 Mg, Prn) (View Prexige Review and Prexige Label ), HYDERGINE (1 Mg, Qd) (View Hydergine Review and Hydergine Label ).

5509614-9 | Blood Pressure Increased, Dyspnoea, Left Ventricular Dysfunction, Palpitations
on Nov 07, 2007 Female patient from UNITED STATES , 27 years of age, weighting 122.0 lb, was diagnosed with headache (What is headache?) and was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: blood pressure increased, dyspnoea, left ventricular dysfunction, palpitations. Pamelor dosage: 10 Mg Qhs Po.

5501611-2 | Amnesia, Dysarthria, Essential Tremor, Heart Rate Increased, Hypertension, Overdose
Patient was taking Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, dysarthria, essential tremor, heart rate increased, hypertension, overdose on Oct 26, 2007 from UNITED STATES Additional patient health information: Female patient , 31 years of age, weighting 265.0 lb, was diagnosed with neck pain and. Pamelor dosage: 75mg 1 A Day Po. Patient was hospitalized.

5487729-1 | Grand Mal Convulsion
Adverse event was reported on Jun 13, 2007 by a Female patient taking Pamelor (View Usage) (Dosage: 25 Mg, Qd, Oral; 50 Mg,qd, Oral; 25 Mg) was diagnosed with depression (What is depression?), migraine (What is migraine?), insomnia and. Location: UNITED STATES , 16 years of age, weighting 252.0 lb, Patient had the following side effects: grand mal convulsion. During the same period patient was treated with ELAVIL (25 Mg) (View Elavil Review and Elavil Label ), WELLBUTRIN (BUPROPION) TABLET (150 Mg, Bid) (View Wellbutrin (bupropion) Tablet Review and Wellbutrin (bupropion) Tablet Label ).

5391883-X | Breast Enlargement, Dry Mouth, Musculoskeletal Pain, Weight Increased
on Jul 03, 2007 Female patient from UNITED STATES , 55 years of age, weighting 147.9 lb, was diagnosed with anxiety (What is anxiety?), panic attack and was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: breast enlargement, dry mouth, musculoskeletal pain, weight increased. Pamelor dosage: . During the same period patient was treated with NORTRIPTYLINE HCL (One Capsule Qpm, Oral) (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

5378121-9 | Abdominal Pain Upper, Asphyxia, Back Pain, Chest Pain, Emotional Disorder, Face Oedema, Headache, Influenza Like Illness, Nasopharyngitis
on Jun 26, 2007 Female patient from BRAZIL , 53 years of age, weighting 149.9 lb, was diagnosed with depression (What is depression?) and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asphyxia, back pain (What is back pain?), chest pain (What is chest pain?), emotional disorder, face oedema, headache (What is headache?), influenza like illness, nasopharyngitis. Pamelor dosage: 25 Mg/day. During the same period patient was treated with ARCOXIA (90 Mg, Bid) (View Arcoxia Review and Arcoxia Label ), LEXOTAN (3 Mg, Qd) (View Lexotan Review and Lexotan Label ), GERIATON (1 Tablet/day) (View Geriaton Review and Geriaton Label ), SYMBICORT (100 Mg, Unk) (View Symbicort Review and Symbicort Label ), DIOSMIN (500 Mg, Unk) (View Diosmin Review and Diosmin Label ), EUTHYROX (75 Mg, Qd) (View Euthyrox Review and Euthyrox Label ).

5279685-6 | Benign Prostatic Hyperplasia, Urinary Tract Obstruction
Patient was taking Pamelor (View Usage). Patient had the following side effects: benign prostatic hyperplasia, urinary tract obstruction on Mar 09, 2007 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with depression (What is depression?) and. Pamelor dosage: . During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

5271376-0 | Bedridden, Brugada Syndrome, Cerebral Ischaemia, Clonic Convulsion, Dry Mouth, Electrocardiogram St Segment Elevation, Syncope, Tremor
Adverse event was reported on Mar 02, 2007 by a Male patient taking Pamelor (View Usage) (Dosage: 30-150 Mg, Qd, Unk) was diagnosed with depression (What is depression?) and. Location: JAPAN , 43 years of age, After Pamelor was administered, patient had the following side effects: bedridden, brugada syndrome, cerebral ischaemia, clonic convulsion, dry mouth, electrocardiogram st segment elevation, syncope, tremor. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), MILNACIPRAN (MILNACIPRAN) (View Milnacipran (milnacipran) Review and Milnacipran (milnacipran) Label ).

5261512-4 | Brugada Syndrome, Syncope
on Feb 22, 2007 Male patient from JAPAN , 43 years of age, was diagnosed with depression (What is depression?) and was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: brugada syndrome, syncope. Pamelor dosage: .

5226737-2 | Completed Suicide
on Nov 30, 2006 Female patient from UNITED STATES , 69 years of age, was treated with Pamelor (View Usage). Patient had the following side effects: completed suicide. Pamelor dosage: Oral. During the same period patient was treated with QUETIAPINE FUMARATE (Oral) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), VERAPAMIL (Oral) (View Verapamil Review and Verapamil Label ).

5226736-0 | Completed Suicide
Patient was taking Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: completed suicide on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 46 years of age, . Pamelor dosage: Oral. During the same period patient was treated with VALPROIC ACID (Oral) (View Valproic Acid Review and Valproic Acid Label ), VERAPAMIL (Oral) (View Verapamil Review and Verapamil Label ).

5226735-9 | Agitation, Blood Creatinine Increased, Blood Urea Increased, Cardiac Disorder, Electrocardiogram Abnormal, Electrocardiogram Qrs Complex Prolonged, Fall
Adverse event was reported on Nov 30, 2006 by a Female patient taking Pamelor (View Usage) (Dosage: Oral) . Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: agitation, blood creatinine increased, blood urea increased, cardiac disorder, electrocardiogram abnormal, electrocardiogram qrs complex prolonged, fall (What is fall?).

5226734-7 | Cardio-respiratory Arrest, Completed Suicide
on Nov 30, 2006 Female patient from UNITED STATES , 49 years of age, was treated with Pamelor (View Usage). Patient had the following side effects: cardio-respiratory arrest, completed suicide. Pamelor dosage: Oral. During the same period patient was treated with AMITRIPTYLINE HCL (Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), FENTANYL (Transdermal) (View Fentanyl Review and Fentanyl Label ).

5226733-5 | Cardio-respiratory Arrest, Completed Suicide, Heart Rate Increased, Refusal Of Treatment By Patient
on Nov 30, 2006 Male patient from UNITED STATES , 20 years of age, was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: cardio-respiratory arrest, completed suicide, heart rate increased, refusal of treatment by patient. Pamelor dosage: 100 Tablets, Oral. During the same period patient was treated with HALOPERIDOL (Oral) (View Haloperidol Review and Haloperidol Label ), ASPIRIN (30 Tablets, Oral) (View Aspirin Review and Aspirin Label ).

5226732-3 | Cardio-respiratory Arrest, Completed Suicide
Patient was taking Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, completed suicide on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 28 years of age, . Pamelor dosage: Oral. During the same period patient was treated with VENLAFAXINE HCL (Oral) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), QUETIAPINE FUMARATE (Oral) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

5226231-9 |
Adverse event was reported on Nov 30, 2006 by a Female patient taking Pamelor (View Usage) (Dosage: Oral) . Location: UNITED STATES , 40 years of age, .

5226230-7 | Completed Suicide
on Nov 30, 2006 Female patient from UNITED STATES , 53 years of age, was treated with Pamelor (View Usage). After Pamelor was administered, patient had the following side effects: completed suicide. Pamelor dosage: Oral.

5226219-8 | Completed Suicide
on Nov 30, 2006 Female patient from UNITED STATES , 36 years of age, was treated with Pamelor (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Pamelor dosage: Oral. During the same period patient was treated with HYDROCODONE/ACETAMINOPHEN (HYDROCODONE BITARTRATE, ACETAMINOPHEN) (Oral) (View Hydrocodone/acetaminophen (hydrocodone Bitartrate, Acetaminophen) Review and Hydrocodone/acetaminophen (hydrocodone Bitartrate, Acetaminophen) Label ), OLANZAPINE (Oral) (View Olanzapine Review and Olanzapine Label ).

5226209-5 | Completed Suicide
Patient was taking Pamelor (View Usage). Patient had the following side effects: completed suicide on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 19 years of age, . Pamelor dosage: Oral. During the same period patient was treated with ETHANOL (ETHANOL) (Oral) (View Ethanol (ethanol) Review and Ethanol (ethanol) Label ), TOPIRAMATE (Oral) (View Topiramate Review and Topiramate Label ).